KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Enterprise Value (2018 - 2026)

Cardlytics filings provide 11 years of Enterprise Value readings, the most recent being -$59.8 million for Q1 2026.

  • Quarterly Enterprise Value fell 14.9% to -$59.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$59.8 million through Mar 2026, down 14.9% year-over-year, with the annual reading at -$48.7 million for FY2025, 25.73% up from the prior year.
  • Enterprise Value hit -$59.8 million in Q1 2026 for Cardlytics, down from -$48.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$44.0 million in Q3 2025 and bottomed at -$208.3 million in Q1 2022.
  • Average Enterprise Value over 5 years is -$93.6 million, with a median of -$90.1 million recorded in 2023.
  • The largest annual shift saw Enterprise Value skyrocketed 66.05% in 2022 before it fell 14.9% in 2026.
  • Cardlytics' Enterprise Value stood at -$121.9 million in 2022, then rose by 24.67% to -$91.8 million in 2023, then rose by 28.57% to -$65.6 million in 2024, then rose by 25.73% to -$48.7 million in 2025, then decreased by 22.75% to -$59.8 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Enterprise Value are -$59.8 million (Q1 2026), -$48.7 million (Q4 2025), and -$44.0 million (Q3 2025).